Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate

Search for:

Trump 2.0
Trump 2.0
Public Health
Public Health
All Public Health
Audio Reports
Audio Reports
All Audio
Special Reports
Special Reports
All Special Reports
More Topics
More Topics
All Topics

Medicare Advantage Billing Probe
School Vaccine Mandates
Weight Loss Drugs Coverage
Opioid Settlement Money
Abortion Pill Access

Search for:

Archives: Morning Breakouts

24,861-24,880 of 113,179 results

Senate Finance’s Sweeping Drug Prices Bill Moves Forward But It Has A Bumpy Path In Front Of It

In particular, a provision that would cap drug prices paid by Medicare based on the rate of inflation has sparked some pushback even among Republicans who voted to advance the long-awaited bill. And Democrats, who unanimously voted to advance the bill, may still kill it. Senate Finance Chairman Chuck Grassley (R-Iowa) is trying to make the case that lawmakers may not like his bill, but they'll dislike what the Trump administration and House Democrats come up with more.

By brilabuskes

July 26, 2019
First Edition: July 26, 2019

Today's early morning highlights from the major news organizations.

By brilabuskes

July 26, 2019
Research Roundup: Infant Deaths; Type 2 Diabetes Risks; Aging; And Health Care Spending

Each week, KHN compiles a selection of recently released health policy studies and briefs.

By brilabuskes

July 25, 2019
Viewpoints: Public Option Is A Trojan Horse For Unsustainable Single-Payer System; ‘Cadillac Tax’ May Be Unpopular But It Should Be Retained

Editorial and opinion writers look at a broad range of health topics from the Affordable Care Act to food stamps to drug pricing and more.

By brilabuskes

July 25, 2019
Critical Medical Mystery Illuminates The Dramatic Role AI Could Play Not In Replacing Doctors But Guiding Them

Doctors can be left flummoxed by symptoms they've never seen before. That's where artificial intelligence can step in and offer cases that might hold key answers for those racing to save lives. In other public health news: vaccines, precision medicine, baby powder and cancer, the social effects of TV, robotic hands, and more.

By brilabuskes

July 25, 2019
State Highlights: Oregon Makes It Easier For Most-Critical Patients To Access Aid-In-Dying Meds Quicker; 125,000 Texans Could Lose SNAP Benefits Under New Rule

Media outlets report on news from Oregon, Texas, New Hampshire, Florida, Iowa, Colorado, Minnesota, Maryland, California and North Carolina.

By brilabuskes

July 25, 2019
Only About One In Three High-Risk Americans Take PrEP Despite Proven Effectiveness Of Drug To Protect Against HIV

Among the men in the survey, PrEP use rose steeply from 2014 to 2017, from 6 percent to 35 percent, but large racial disparities still persist.

By brilabuskes

July 25, 2019
The Cost Of Unwarranted ER Visits: $32 Billion A Year

A trip to the emergency room is on average 12 times higher than being treated at a physician's office for common ailments, an analysis from UnitedHealth Group found. The claims data showed ailments frequently treated in the emergency room include cough, bronchitis, headache, sore throat, nausea and upper respiratory infection, which may not actually need emergency care.

By brilabuskes

July 25, 2019
‘A Slow-Moving Train Wreck’: Most Americans Don’t Have Long-Term Care Insurance Yet Many Will Need It

States are trying to avert the upcoming catastrophe with plans that support care for aging residents. The moves come as Americans are having fewer children and living longer — in many instances, living longer with chronic conditions such as dementia.

By brilabuskes

July 25, 2019
Anthem Beats Q2 Expectations But Worries About Medicaid Business Has Shares Sliding

The company’s medical-loss ratio, which represents the share of premiums paid out in claims, was 86.7% in the quarter, higher than the 85.8% that a consensus of analysts had anticipated, according to their research notes. In other health industry news: a social care network from CVS and Aetna, Tenet's decision to spin off as a separate company, Bayer's legal mess, and more.

By brilabuskes

July 25, 2019
Threats To Marketplace From Lawmakers, Administration Wearing Thin On Health Care Investors

"There are a significant number of investors who are completely on the sidelines from the industry,” SVB Leerink biopharma analyst Geoffrey Porges said. “And you can pick your ‘until’: until the proposed rule on Medicare international reference pricing is announced, or until the next Democratic debate, or until the election. There’s a lot of ‘until’s.”

By brilabuskes

July 25, 2019
A Look At Defense Tactics Expected In Opioid Case: No Evidence Shows Drugmakers–Not Criminal Cartels–Caused Crisis

In response, the plaintiffs need to show that the companies were conspiring with one another and acting in concert, a person familiar with the defense's strategy tells The Washington Post. That’s difficult to do because the companies are fierce competitors. Meanwhile, under oath, Cardinal Health counsel Jennifer Norris said that her company has no obligation to protecting public health. And an Associated Press analysis found that the amount of opioids as measured by total potency continued to rise early this decade even as the number of pills distributed began to dip.

By brilabuskes

July 25, 2019
Sanders Targets Racial Disparities In Medicine With Plan To Boost Number Of Minority Medical Professionals

“When we are in the White House, we will address the need for more black doctors, more black dentists, more black nurses and more black mental health providers who can provide culturally competent care in their communities," said Sen. Bernie Sanders (I-Vt.), a 2020 hopeful. Meanwhile Sanders' campaign continued to go after former Vice President Joe Biden for his rhetoric over "Medicare for All."

By brilabuskes

July 25, 2019
Senate’s Measure Targeting High Health Care Costs, Surprise Medical Bills Kicked To The Fall

Although Senate health committee Chair Lamar Alexander (R-Tenn.) had previously said he hoped to get something out before recess, it's now looking like the measure won't be done until lawmakers come back after August.

By brilabuskes

July 25, 2019
Legislation Setting Health Care, Safety And Hygiene Standards For Detained Immigrants Passes House

Along with the standards, the legislation bars Border Patrol from denying lawmakers access to the facilities and it directs the agency to provide adequate training for its officers to carry out the new requirements. In other news on the immigration crisis: HHS plans to phase out temporary facilities to hold detained children and officials testify that the agency is still sharing information about separated families.

By brilabuskes

July 25, 2019
Textured Breast Implants That Have Been Linked To Unusual Cancer To Be Recalled Globally

The recall in the United States was at the request of the FDA, which said that more than 80 percent of the 570 confirmed cases of the lymphoma worldwide have been linked to Allergan implants. The agency is not recommending women with the implants have them removed because the cancer is so rare.

By brilabuskes

July 25, 2019
Medicare Spent $2.8 Billion On Drugs That Other Wealthy Countries Wouldn’t Cover Or Recommend

“Other developed nations assessed drugs based on value ... but the U.S. remains one of the few developed nations that doesn’t," said Alexander Egilman, a researcher at Yale. "We all say we spend too much on drugs, and this approach seems to be working for other countries, based on outcomes, such as lifespans. So why aren’t we considering this?” In other pharmaceutical news: dark money, former FDA chief Scott Gottlieb's new position, off-label marketing practices, and more.

By brilabuskes

July 25, 2019
Trump Cooking Up A Sweeping Executive Order That Would Cut Drug Prices In Medicare’s Part D Program, Sources Say

According to reporting from Reuters, sources say the proposal would be much broader than the administration’s previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries.

By brilabuskes

July 25, 2019
Senate’s Proposed Package To Target High Drug Prices Is A Big Overhaul That Comes With Even Bigger Questions

The bipartisan proposal released from the Senate Finance Committee this week has won praise from a number of Washington’s loudest drug pricing advocates, but the magnitude of the proposal has even some of Washington’s most outspoken drug pricing experts grappling with its long-term implications. Meanwhile, HHS Secretary Alex Azar is throwing his weight behind the legislation.

By brilabuskes

July 25, 2019
First Edition: July 25, 2019

Today's early morning highlights from the major news organizations.

By brilabuskes

July 25, 2019

Posts pagination

1 … 1,243 1,244 1,245 … 5,659

Podcasts
Special Reports
Morning Briefing

About Us
Donate
Staff
Republish Our Content
Contact Us

Follow Us

Instagram
YouTube
LinkedIn
Facebook
X
Bluesky
TikTok
RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up

Editorial Policy
Privacy Policy

© 2026 KFF